GLP-1 receptor agonists have known satiety-promoting effects due to central action of the neuropeptide GLP-1 [1], with reduced activation of appetite- and reward-related brain areas in response to food [18]
GPX4 has been found at high levels in cancer cells and contributes to drug-resistance against lapatinib, palbociclib and other anti-cancer drugs
Its a growth hormone releasing hormone (GHRH) analog, meaning it mimics the hormone your brain naturally uses to trigger growth hormone production
FACS data from VEGF, CXCL-8 and Angiogenin, were validated by Bioplex [30], on CMs from PC-3, DU-145 and LNCaP cells, following 24 h of treatment with ALCAR 1 mM
Since starting GLP-1 medication, Ive been tracking my BMR with a RENPHO Smart Scale